Injective (INJ) is currently priced at $5.25, experiencing a notable 24-hour decline of 12.17%. The daily trading range has been relatively tight, with a high of $6.05 and a low of $4.93, reflecting a volatility of 1.12%.

Volume remains robust at approximately $343.69 million, with a volume-to-market cap ratio of 65.48%. This indicates strong trading activity and interest, which could contribute to price recovery in the near term.

Examining the moving averages, the 8-period SMA is at $5.09, showing a positive change of 3.11%, while the 55-period SMA at $5.03 has increased by 4.39%. In contrast, the 21-period SMA at $5.35 has decreased by 1.81%, suggesting a mixed short-term sentiment.

The 1-hour RSI is at 48, indicating a neutral momentum, while the 7-day RSI at 58 signals a slight bullish trend. Over the past week, INJ has gained approximately 35.50%, with 14-day and 30-day price changes of 52.29% and 73.54%, respectively, showcasing strong upward momentum over a longer timeframe.

Injective's all-time high stands at $52.62, reached on March 14, 2024, highlighting significant upside potential from the current price level. Given the recent price decline and the supportive moving averages, a recovery towards previous resistance levels is plausible, contingent on market conditions.

Based on the current technical indicators and strong trading volume, I rate INJ as a Buy. The favorable moving averages and positive long-term price changes suggest that the cryptocurrency may rebound from its current dip, offering a good entry point for potential gains.